Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-08 4:43 pm Purchase |
2023-05-04 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 4,553,489 9.900% |
1,017,000 (+28.76%) |
Filing History |
| 2023-03-17 4:19 pm Purchase |
2023-02-27 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 3,536,489 10.500% |
3,536,489 (New Position) |
Filing History |
| 2023-03-08 5:22 pm Purchase |
2023-02-27 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 275,099 8.100% |
275,099 (New Position) |
Filing History |
| 2023-02-14 12:53 pm Purchase |
2022-12-31 | 13G | BiomX Inc. PHGE |
MMCAP International Inc. SPC | 222,288 7.080% |
10,724 (+5.07%) |
Filing History |
| 2023-02-13 3:57 pm Sale |
2022-12-31 | 13G | BiomX Inc. PHGE |
Ugwumba Chidozie | 92,280 3.070% |
-207,423 (-69.21%) |
Filing History |
| 2022-11-14 5:10 pm Sale |
2022-11-04 | 13G | BiomX Inc. PHGE |
Ugwumba Chidozie | 299,703 9.990% |
-251,582 (-45.64%) |
Filing History |
| 2022-08-04 7:59 pm Unchanged |
2022-03-25 | 13G | BiomX Inc. PHGE |
TAKEDA PHARMACEUTICAL CO LTD | 147,829 4.960% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:09 pm Sale |
2021-12-31 | 13G | BiomX Inc. PHGE |
Walton Thomas Layton | 0 0.000% |
-551,285 (Position Closed) |
Filing History |
| 2022-02-14 3:49 pm Purchase |
2021-12-31 | 13G | BiomX Inc. PHGE |
Ugwumba Chidozie | 551,285 19.280% |
551,285 (New Position) |
Filing History |
| 2022-02-03 8:37 pm Purchase |
2021-12-31 | 13G | BiomX Inc. PHGE |
MMCAP International Inc. SPC | 211,564 7.500% |
71,559 (+51.11%) |
Filing History |
| 2021-10-18 06:03 am Sale |
2021-10-14 | 13G | BiomX Inc. PHGE |
TAKEDA PHARMACEUTICAL CO LTD | 147,829 5.200% |
-99,265 (-40.17%) |
Filing History |
| 2021-08-09 4:27 pm Purchase |
2021-07-28 | 13G | BiomX Inc. PHGE |
Walton Thomas Layton | 551,285 17.800% |
551,285 (New Position) |
Filing History |
| 2021-02-12 5:11 pm Purchase |
2020-12-31 | 13G | BiomX Inc. PHGE |
MMCAP International Inc. SPC | 140,005 5.860% |
25,599 (+22.38%) |
Filing History |